is tirzepatide in mounjaro FDA approves new version of diabetes drug to be sold for weight loss Mounjaro (tirzepatide) + GLP-1 support
Description
Semaglutide is FDA-approved for obesity at BMI 30+, but doctors may prescribe it off-label for lower BMIs when other health factors apply
Gastrointestinal side effects, including diarrhea, affect up to 25% of GLP-1 users during early treatment phases
Support for weight management goals
Meal Replacement Shakes for Weight Loss: Which is the Safer Choice
Unlock your weight loss potential with and achieve real results with our customized tirzepatide weight loss program.
